Skip to main content
Premium Trial:

Request an Annual Quote

CLC Bio To Provide Custom Bioinformatics Platform for ACE BioSciences

NEW YORK (GenomeWeb News) – ACE BioSciences has tapped CLC Bio to develop a customized bioinformatics platform that will support its work in vaccine target discovery and validation, CLC Bio said today.
 
Under the terms of the agreement, CLC Bio will upgrade ACE BioSciences' current bioinformatics platform to ensure that the firm can compare, rank, and prioritize potential vaccine targets.
 
The solution will include several of CLC Bio’s workbenches for DNA, RNA, and protein sequence analysis, as well as customized modules that will be proprietary for ACE BioSciences
 
Financial terms of the agreement were not provided.

The Scan

Facial Imaging-Based Genetic Diagnoses Appears to Get Boost With Three-Dimensional Approach

With data for more than 1,900 individuals affected by a range of genetic conditions, researchers compared facial phenotype-based diagnoses informed by 2D or 3D images in the European Journal of Human Genetics.

Survey Suggests Multigene Cancer Panel VUS Reporting May Vary Across Genetic Counselors

Investigators surveyed dozens of genetic counselors working in clinical or laboratory settings, uncovering attitudes around VUS reporting after multigene cancer panel testing in the Journal of Genetic Counseling.

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.